 | Up a level |
Noti, Luca; Galván, José; Dawson, Heather; Lugli, Alessandro; Kirsch, Richard; Assarzadegan, Naziheh; Messenger, David; Krebs, Philippe; Berger, Martin D; Zlobec, Inti (2022). A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer. BMC cancer, 22(1), p. 987. BioMed Central 10.1186/s12885-022-10048-x
Rhyner Agocs, Gaëlle; Assarzadegan, Naziheh; Kirsch, Richard; Dawson, Heather; Galván, José A.; Lugli, Alessandro; Zlobec, Inti; Berger, Martin D. (2021). LAG-3 Expression Predicts Outcome in Stage II Colon Cancer. Journal of personalized medicine, 11(8) MDPI 10.3390/jpm11080749
Forse, Catherine L; Rahimi, Mahdi; Diamandis, Eleftherios P; Assarzadegan, Naziheh; Dawson, Heather; Grin, Andrea; Kennedy, Erin; O'Connor, Brenda; Messenger, David E; Riddell, Robert H; Kirsch, Richard; Karagiannis, George S (2017). HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. Experimental and molecular pathology, 103(1), pp. 94-100. Elsevier 10.1016/j.yexmp.2017.07.002
Koelzer, Viktor H; Assarzadegan, Naziheh; Dawson, Heather; Mitrovic, Bojana; Grin, Andrea; Messenger, David E; Kirsch, Richard; Riddell, Robert H; Lugli, Alessandro; Zlobec, Inti (2017). Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience. The journal of pathology: clinical research, 3(3), pp. 171-178. Wiley 10.1002/cjp2.73
